Galapagos NV
GLPG
#4517
Rank
โ‚น203.32 B
Marketcap
โ‚น3,085
Share price
1.94%
Change (1 day)
37.49%
Change (1 year)

P/E ratio for Galapagos NV (GLPG)

P/E ratio as of March 2026 (TTM): -99.3

According to Galapagos NV's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -99.3465. At the end of 2024 the company had a P/E ratio of 23.4.

P/E ratio history for Galapagos NV from 2015 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202423.4104.48%
202311.5-191.92%
2022-12.5-59.81%
2021-31.079.18%
2020-17.3-124.16%
201971.6-150.69%
2018-141323.07%
2017-33.4-164.57%
201651.7-399.85%
2015-17.2-222.8%
201414.0-125.86%
2013-54.3-27%
2012-74.4

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Johnson & Johnson
JNJ
22.0-122.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
30.2-130.37%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
98.7-199.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
22.4-122.53%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
16.5-116.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
37.7-137.92%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
15.1-115.18%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-5.08-94.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
26.5-126.71%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.